Dexamethasone and Carpal tunnel decompression - a phase IV clinical study of FDA data

Summary:

Carpal tunnel decompression is found among people who take Dexamethasone, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Dexamethasone and have Carpal tunnel decompression. It is created by eHealthMe based on reports of 80,228 people who have side effects when taking Dexamethasone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 22, 2022

80,228 people reported to have side effects when taking Dexamethasone.
Among them, 13 people (0.02%) have Carpal tunnel decompression.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 80,824 Dexamethasone users for its effectiveness, alternative drugs and more.

What is Carpal tunnel decompression?

Carpal tunnel decompression is found to be associated with 463 drugs and 212 conditions by eHealthMe.

Number of Dexamethasone and Carpal tunnel decompression reports submitted per year:

Could Dexamethasone cause Carpal tunnel decompression?

Time on Dexamethasone when people have Carpal tunnel decompression *:

Gender of people who have Carpal tunnel decompression when taking Dexamethasone *:

female: 84.62 %
male: 15.38 %

Age of people who have Carpal tunnel decompression when taking Dexamethasone *:

Common drugs people take besides Dexamethasone *:

Common side effects people have besides Carpal tunnel decompression *:

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 84.62%
Pain: 11 people, 84.62%
Weakness: 10 people, 76.92%
Dental Fistula: 10 people, 76.92%
Dizziness: 10 people, 76.92%
Ear Neoplasm (tour in ear): 10 people, 76.92%
Encephalopathy (functioning of the brain is affected by some agent or condition): 10 people, 76.92%
Face Oedema (swelling of face): 10 people, 76.92%
Gastritis (inflammation of stomach): 10 people, 76.92%
Gingival Infection (gum infection): 10 people, 76.92%

Common conditions people have *:

Pain: 10 people, 76.92%
Metastases To Bone (cancer spreads to bone): 10 people, 76.92%
Type 2 Diabetes: 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Erection Problems: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have Carpal tunnel decompression?

Check whether Carpal tunnel decompression is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

Related studies

Alternative drugs to, pros and cons of Dexamethasone:

Dexamethasone (80,824 reports)

Carpal tunnel decompression treatments and more:

Carpal tunnel decompression (1,045 reports)

COVID vaccines that are related to Carpal tunnel decompression:

How severe was Carpal tunnel decompression and when was it recovered:

Carpal tunnel decompression in Dexamethasone

Expand to all the drugs that have ingredients of dexamethasone:

Carpal tunnel decompression and drugs with ingredients of dexamethasone

Common drugs associated with Carpal tunnel decompression:

Enbrel: 127 reports
Fosamax: 155 reports

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.